BROKEN STRING BIOSCIENCES LIMITED

Active United Kingdom

Research and experimental development on biotechnology

29 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BROKEN STRING BIOSCIENCES LIMITED

Research and experimental development on biotechnology

Founded 23 Jan 2020 Active United Kingdom 29 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 12 Apr 2026 Next due 8 Apr 2027 11 months remaining
Net assets £8M £917K 2024 year on year
Total assets £8M £1M 2024 year on year
Total Liabilities £718K £286K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BROKEN STRING BIOSCIENCES LIMITED (12420619), an active life sciences and medical technology company based in United Kingdom. Incorporated 23 Jan 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£6.35M

Increased by £410.04k (+7%)

Net Assets

£7.63M

Increased by £916.86k (+14%)

Total Liabilities

£718.40k

Increased by £285.85k (+66%)

Turnover

N/A

Employees

29

Increased by 25 (+625%)

Debt Ratio

9%

Increased by 3 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Feb 2021Seed
Investor 5Sept 2021Series A, Seed
Investor 6Sept 2021Series A, Seed

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 3,584,240 Shares £17.89m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Oct 20251,934,523£4.87m£2.52
18 Jul 20252,397£0.24£0
28 Jun 20252,573£4k£1.52
6 Feb 2025105£159.6£1.52
7 Oct 2024613,388£6.13m£9.99

Officers

Officers

2 active 1 resigned
Status
Crutchfield, Bradford JamesDirectorAmericanUnited States6329 Aug 2024Active
Reid, Laurence Edward, DrDirectorAmerican,britishUnited States6229 Aug 2024Active

Shareholders

Shareholders (25)

Illumina Innovation Fund Ii, Lps
14.1%
413,639
M?rieux Equity Partners
14.1%
413,639

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Professor Simon Huw Reed

Ceased 7 Sept 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-25 with updates
24 Nov 2025OfficersChange to director Felix Dobbs on 2025-11-24
21 Nov 2025OfficersChange to director Mr Francois Rosenfeld on 2025-11-21
19 Nov 2025CapitalAllotment of shares (GBP 488.2436) on 2025-10-31
14 Nov 2025IncorporationMemorandum Articles
12 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-25 with updates

24 Nov 2025 Officers

Change to director Felix Dobbs on 2025-11-24

21 Nov 2025 Officers

Change to director Mr Francois Rosenfeld on 2025-11-21

19 Nov 2025 Capital

Allotment of shares (GBP 488.2436) on 2025-10-31

14 Nov 2025 Incorporation

Memorandum Articles

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-25 with updates

1 weeks ago on 12 Apr 2026

Change to director Felix Dobbs on 2025-11-24

4 months ago on 24 Nov 2025

Change to director Mr Francois Rosenfeld on 2025-11-21

5 months ago on 21 Nov 2025

Allotment of shares (GBP 488.2436) on 2025-10-31

5 months ago on 19 Nov 2025

Memorandum Articles

5 months ago on 14 Nov 2025